Answers are grounded in this paper and cite their sources.
Recent evidence suggests that antiglucocorticoids, like conventional antidepressants, may recover depressive symptoms by boosting hippocampal neurogenesis. Here, we explore several possible antiglucocorticoid-based antidepressive therapeutic strategies. Firstly, we review specific glucocorticoid receptor/antagonist interactions. Secondly, we discuss a potential new therapeutic target, doublecortin-like kinase, which regulates glucocorticoid signaling in neuronal progenitor cells.
No takes yet. Share an insight, caveat, or question.
Fitzsimons et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: